Page last updated: 2024-09-04

carbapenems and Ventilator-Associated Pneumonia

carbapenems has been researched along with Ventilator-Associated Pneumonia in 88 studies

Research

Studies (88)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	14 (15.91)	29.6817
2010's	52 (59.09)	24.3611
2020's	22 (25.00)	2.80

Authors

Authors	Studies
Agarwal, A; Arshad, Z; Gupta, P; Kumari, M; Prakash, V; Siddiqui, SS; Tripathi, P; Venkatesh, V; Verma, S	1
Alvi, AA; Ishtiaq, S; Saleem, S; Waheed, A	1
Burnham, J; Honda, H; Kollef, M; Lizza, B; Miwa, T	1
Alquethamy, SF; Bauer, MJ; Beatson, SA; Blaskovich, MAT; Brouwer, S; Cork, AJ; De Oliveira, DMP; El-Deeb, IM; Forde, BM; Harbison-Price, N; Keller, N; Li, G; McDevitt, CA; McEwan, AG; Paterson, DL; Phan, MD; Roberts, JA; Schembri, MA; Steiner, B; von Itzstein, M; Walker, MJ; Zhang, B; Zuegg, J	1
Barnini, S; Della Sala, L; Falcone, M; Farcomeni, A; Leonildi, A; Menichetti, F; Tiseo, G; Vecchione, A	1
Nathanson, BH; Puzniak, LA; Shorr, AF; Zilberberg, MD	1
Abdul-Aziz, MH; Bassetti, M; de Montmollin, E; Giacobbe, DR; Roberts, JA; Timsit, JF	1
Chen, S; Zou, D	1
Dillon, RJ; Nathanson, BH; Puzniak, LA; Shorr, AF; Zilberberg, MD	1
Chen, J; Ding, X; Du, B; Gao, S; Hu, Y; Liu, D; Ma, D; Ma, L; Ma, X; Meng, X; Shan, G; Su, L; Sun, G; Zhang, F; Zhou, X; Zhu, W	1
Chan, MC; Chen, CM; Chen, CY; Chou, YC; Feng, JY; Lin, YC; Peng, CK; Sheu, CC; Wang, SH; Yang, KY; Zheng, ZR	1
Chen, C; Huang, Y; Minhua, S; Pan, X; Pei, Y; Qian, B; Xing, Y; Yao, Z; Zhong, A; Zhou, T	1
Borrazzo, C; Bruni, A; Garofalo, E; Gullì, S; Lionello, R; Longhini, F; Marascio, N; Matera, G; Quirino, A; Romeo, F; Russo, A; Serapide, F; Serraino, R; Torti, C; Trecarichi, EM	1
Chan, MC; Chen, CM; Feng, JY; Hsu, HS; Kao, HH; Lin, YC; Lin, YT; Peng, CK; Shen, YC; Sheu, CC; Wang, SH; Yang, KY; Zheng, ZR	1
Akalın, H; Girgin, NK; İşçimen, R; Kahveci, FŞ; Kaya, PK; Önal, U; Özakın, C; Tüzemen, NÜ	1
Azoulay, E; Bédos, JP; Bouadma, L; Darmon, M; de Montmollin, E; Garrouste-Orgeas, M; Ibn Saied, W; Le Monnier, A; Marcotte, G; Merceron, S; Mourvillier, B; Oziel, J; Papazian, L; Reignier, J; Ruckly, S; Schwebel, C; Siami, S; Souweine, B; Timsit, JF	1
Abner, S; Benin, AL; Dudeck, MA; Edwards, JR; Kallen, AJ; Karlsson, M; Magill, SS; Pollock, D; See, I; Soe, MM; Walters, MS; Weiner-Lastinger, LM	1
Brito, JCM; da Cruz Nizer, WS; Lima, WG	1
Alves da Silva, LM; Bento Talizin, T; Boll, KM; Dantas de Maio Carrilho, CM; Festti, J; Magalhães Carvalho Grion, C; Medeiros, EA; Moro Kauss, IA; Paes, K; Patruceli de Azevedo, I; Ribeiro Lopes, C; Tibery Queiroz Cardoso, L; Toshiyuki Tanita, M	1
Arodhia, S; Bajaj, R; Kaur, L; Singh, M	1
Chandrakar, S; Jain, G; Patel, NB; Walikar, BN	1
Carvalhaes, C; Castanheira, M; Deshpande, L; Shortridge, D	1
Baker, S; Campbell, JI; Edwards, DJ; Fournier-Level, A; Hall, RM; Hawkey, J; Holt, KE; Ingle, DJ; Kenyon, JJ; Pham Thanh, D; Phu Huong Lan, N; Schultz, MB; Thi Khanh Nhu, N; Thwaites, G; Tran Do Hoan, N; Wick, RR	1
Pilmis, B; Timsit, JF; Zahar, JR	1
Bassetti, M; Carnelutti, A; Peghin, M; Righi, E	1
Fisher, K; Juang, P; Kollef, MH; Micek, ST; Trupka, T	1
Cao, J; Hu, Y; Huang, JJ; Jin, Z; Que, CL; Wang, GF; Wang, X; Zhang, H; Zhang, W	1
Lake, JG; Magill, SS; Milstone, AM; Saiman, L; See, I; Weiner, LM	1
Aubry, A; Bréchot, N; Brossier, F; Jarlier, V; Lu, Q; Luyt, CE; Micaëlo, M; Monsel, A	1
Argaud, L; Azoulay, É; Bailly, S; Barbier, F; Darmon, M; de Montmollin, É; Goldgran-Toledano, D; Kallel, H; Marcotte, G; Misset, B; Mourvillier, B; Papazian, L; Reignier, J; Schwebel, C; Siami, S; Souweine, B; Timsit, JF; Zahar, JR	1
Brasiliense, DM; de Oliveira Souza, C; Dutra, LMG; Lima, KVB; Mamizuka, EM; McCulloch, JA; Pérez-Chaparro, PJ	1
Abdollahi, A; Beigmohammadi, MT; Doomanlou, M; Khalili, H; Mohammadi, M; Shojaei, L	1
Fan, W; Nathanson, BH; Shorr, AF; Sulham, K; Zilberberg, MD	1
Adukauskienė, D; Čiginskienė, A; Dambrauskienė, A; Rello, J	1
DePestel, DD; DeRyke, CA; Gupta, V; Merchant, S; Murray, J; Puzniak, L; Srinivasan, A; Ye, G	1
Niederman, MS	1
Kalkan, G; Kara, SS; Polat, M; Simsek, H; Tapisiz, A; Tezer, H	1
Caio, C; Ceccarelli, G; Falcone, M; Giordano, A; Mezzatesta, ML; Stefani, S; Venditti, M	1
Davies, TA; He, W; Lynch, AS; Queenan, AM	1
Aubry, A; Bréchot, N; Brisson, H; Brossier, F; Chastre, J; Combes, A; Jarlier, V; Lu, Q; Luyt, CE; Micaelo, M; Rouby, JJ; Trouillet, JL	1
Apisarnthanarak, A; Khawcharoenporn, T; Mundy, LM; Pruetpongpun, N; Rutchanawech, S; Tiamsak, P	1
Anh, ND; Chan, WM; Garcia, J; Harijanto, E; Lee, C; Loo, CM; Mustafa, M; Van Kinh, N	1
Baker, S; Campbell, JI; Chau, NVV; Dung, LT; Hien, TT; Hoang, NVM; Lan, NPH; Le, VM; Loan, HT; Nga, NTT; Nga, TVT; Nghia, HDT; Nhu, NTK; Nhu, TDH; Parry, CM; Tam, PTT; Thompson, C; Thuy, CT; Thwaites, G; Thwaites, L; Tuyen, HT; Van Hao, N; Van Minh, P; Yen, LM; Yen, NTT	1
Dantas, RC; Faria, ALS; Ferreira, ML; Gonçalves, IR; Gontijo-Filho, PP; Queiroz, LL; Ribas, RM; Silveira de Brito, C	1
Doi, Y; Ernst, RK; Hittle, LE; O'Hara, JA; Pasculle, AW; Qureshi, ZA; Rivera, JI; Shields, RK; Syed, A	1
Acikgoz, ZC; Guner, R; Guven, T; Izdes, S; Kocak Tufan, Z; Tasyaran, MA; Yilmaz, GR	1
Chaiwarith, R; Inchai, J; Khositsakulchai, W; Liwsrisakun, C; Pothirat, C; Theerakittikul, T	1
Baker, S; Campbell, JI; Hien, TT; Hoang Nhu, TD; Huong Lan, NP; Le Minh, V; Minh Yen, L; Parry, CM; Thanh Tam, PT; Thi Khanh Nhu, N; Thi Loan, H; Thieu Nga, TV; Thompson, C; Thwaites, G; Thwaites, L; Trung Nghia, HD; Tuyen, HT; Van Hao, N; Van Vinh Chau, N; Vinh Phat, V	1
Aydin, M; Ceylan, MR; Cikman, A; Gulhan, B; Karagoz, A; Karakecili, F; Parlak, M	1
Apisarnthanarak, A; Buppajarntham, A; Khawcharoenporn, T; Rutjanawech, S; Singh, N	1
Dissaneevate, S; Janjindamai, W; Kritsaneepaiboon, S; Maneenil, G; Tanaanantarak, P; Techato, C; Thatrimontrichai, A	1
Aubry, A; Chastre, J; Crandon, JL; Luyt, CE; Nicolau, DP	1
Boucher, A; Boussekey, N; Chiche, A; Delannoy, PY; Georges, H; Leroy, O; Meybeck, A; Patoz, P; Thellier, D; Valette, M	1
Essaied, W; Garrouste-Orgeas, M; Ruckly, S; Schwebel, C; Timsit, JF; Weiss, E; Zahar, JR	1
Badal, RE; Biedenbach, DJ; Giao, PT; Hung Van, P; Phuong, DM; Su Minh Tuyet, N; Thi Thanh Nga, T; Vu Trung, N	1
Arthur, LE; Kizor, RS; Selim, AG; Seoane, L; van Driel, ML	1
Bianco, A; Focà, A; Giordano, M; Liberto, MC; Marano, V; Pavia, M; Quirino, A; Rizzo, C	1
Álvarez-Marín, R; Aznar, J; Cisneros, JM; Garnacho-Montero, J; Gómez, MJ; López-Rojas, R; Márquez, JA; Molina, J; Ortiz-Leyba, C; Pachón, J	1
Cheong, HJ; Heo, JY; Hwang, IS; Kim, WJ; Lee, J; Noh, JY; Song, JY	1
Goff, DA; Mangino, JE; Schafer, JJ	1
Deng, LJ; Kang, Y; Wang, B; Xue, XS	1
Restrepo, MI	1
File, TM; Redman, R	1
Amin, A	1
Akhras, K; DeLong, K; Ingham, M; McGarry, LJ; Merchant, S; Nathwani, D; Pawar, V; Thompson, D; Weinstein, MC	1
Giamarellou, H; Markaki, V; Nanas, S; Paniara, O; Platsouka, E; Pratikaki, M; Roussos, C; Routsi, C; Sotiropoulou, C; Vrettou, C	1
Gast, C; Ketter, N; Kollef, MH; Merchant, S; Nathwani, D; Quintana, A	1
Fujita, M; Ishikura, H; Kitamura, T; Matsumoto, T; Toyoshima, H; Watanabe, K; Yoshimura, C	1
Chen, J; Mody, SH; Shorr, AF; Zilberberg, MD	1
De Waele, JJ; Deja, M; Diaz, E; Guven, M; Koulenti, D; Lisboa, T; Mañez, R; Martin-Loeches, I; Putensen, C; Rello, J; Ulldemolins, M	1
Barbosa, PI; Barth, AL; Carneiro, M; Carrilho, CM; Martins, AF; Perugini, M; Possuelo, LG; Renner, JD; Saridakis, HO; Tanita, MT; Tognin, MC; Valim, AR; Vespero, EC	1
Bernusset, S; Cattoen, C; Cuzon, G; Naas, T; Nordmann, P	1
Apisarnthanarak, A; Mundy, LM	1
Bakšytė, G; Dambrauskienė, A; Macas, A; Sakalauskas, R; Skrodenienė, E; Vitkauskienė, A	1
De Waele, JJ; Lipman, J; Paterson, DL; Roberts, JA; Udy, AA	1
Akduman, D; Aydemir, H; Celebi, G; Comert, F; Horuz, E; Kokturk, F; Ornek, T; Piskin, N; Terzi, A	1
Aeinlang, N; Jaruratanasirikul, S; Jullangkoon, M; Kositpantawong, N; Wongpoowarak, W	1
Chastre, J; Cirillo, I; Clavel, M; Kaniga, K; Kimko, H; Kollef, MH; Michiels, B; Redman, R; Restrepo, MI	1
Martin-Loeches, I; Torres, A	1
Kawano, R; Kikuchi, T; Kuraishi, H; Marumo, K; Nagashima, G; Nemoto, H; Taguchi, K; Tazawa, S; Ugajin, K; Yamanaka, M	1
Archontoulis, N; Giamarellos-Bourboulis, EJ; Giamarellou, H; Mega, A; Pavleas, I; Rigas, K; Thomopoulos, G; Vernikos, P	1
Giamarellos-Bourboulis, E; Koutsoukou, A; Kraniotaki, H; Mentzelopoulos, SD; Nanas, S; Paniara, O; Platsouka, E; Pratikaki, M; Roussos, C; Routsi, C; Zakynthinos, SG; Zervakis, D	1
Chastre, J; Friedland, I; Kaniga, K; Lee, M; Prokocimer, P; Wunderink, R	1
Gilbert, D	1
Friedland, I; Gast, C; Ingham, M; Ketter, N; Lee, M; Merchant, S; Nathwani, D; Quintana, A	1

Reviews

5 review(s) available for carbapenems and Ventilator-Associated Pneumonia

Article	Year
How to use new antibiotics in the therapy of ventilator-associated pneumonia. Current opinion in infectious diseases, 2022, 04-01, Volume: 35, Issue:2 Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa	2022
How Should We Treat Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae? Seminars in respiratory and critical care medicine, 2017, Volume: 38, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Carrier State; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Intensive Care Units; Pneumonia; Pneumonia, Ventilator-Associated; Risk Factors	2017
How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae? Seminars in respiratory and critical care medicine, 2017, Volume: 38, Issue:3 Topics: Anti-Bacterial Agents; Bacteriological Techniques; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Nebulizers and Vaporizers; Pneumonia; Pneumonia, Ventilator-Associated; Renal Insufficiency; Risk Factors	2017
Antibiotics for ventilator-associated pneumonia. The Cochrane database of systematic reviews, 2016, Oct-20, Volume: 10 Topics: Adult; Anti-Bacterial Agents; Carbapenems; Cause of Death; Drug Therapy, Combination; Empirical Research; Humans; Pneumonia, Ventilator-Associated; Randomized Controlled Trials as Topic	2016
Doripenem: a new addition to the carbapenem class of antimicrobials. Recent patents on anti-infective drug discovery, 2009, Volume: 4, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Urinary Tract Infections	2009

Trials

11 trial(s) available for carbapenems and Ventilator-Associated Pneumonia

Article	Year
Meropenem/colistin versus meropenem/ampicillin-sulbactam in the treatment of carbapenem-resistant pneumonia. Journal of comparative effectiveness research, 2018, Volume: 7, Issue:9 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Bacterial; Female; Humans; Male; Meropenem; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Sulbactam	2018
Imipenem, meropenem, or doripenem to treat patients with Pseudomonas aeruginosa ventilator-associated pneumonia. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Disk Diffusion Antimicrobial Tests; Doripenem; Female; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas Infections; Thienamycins	2014
A PROspective study on the Usage patterns of Doripenem in the Asia-Pacific region (PROUD study). International journal of antimicrobial agents, 2014, Volume: 43, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asia; Carbapenems; Doripenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Intensive Care Units; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome; Urinary Tract Infections; Young Adult	2014
Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin. PloS one, 2016, Volume: 11, Issue:12 Topics: Acinetobacter baumannii; Adult; Bacteremia; Carbapenems; Colistin; Disease-Free Survival; Drug Resistance, Multiple, Bacterial; Female; Follow-Up Studies; Humans; Male; Pneumonia, Ventilator-Associated; Prospective Studies; Survival Rate	2016
Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia. Epidemiology and infection, 2013, Volume: 141, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Colistin; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Rifampin; Treatment Outcome	2013
Pharmacodynamics of doripenem in critically ill patients with ventilator-associated Gram-negative bacilli pneumonia. International journal of antimicrobial agents, 2012, Volume: 40, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Critical Illness; Doripenem; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Time Factors	2012
A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia. Critical care (London, England), 2012, Nov-13, Volume: 16, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cilastatin; Doripenem; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Pneumonia, Ventilator-Associated; Young Adult	2012
Impact of carbapenem administration on systemic endotoxemia in patients with severe sepsis and Gram-negative bacteremia. Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; C-Reactive Protein; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Endotoxemia; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; Pneumonia, Ventilator-Associated; Sepsis	2006
Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study. Critical care medicine, 2008, Volume: 36, Issue:4 Topics: Aged; Anti-Bacterial Agents; APACHE; Carbapenems; Doripenem; Female; Hospital Mortality; Humans; Imipenem; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Treatment Outcome	2008
"The truth, if it exists, is in the details". Critical care medicine, 2008, Volume: 36, Issue:4 Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Doripenem; Humans; Imipenem; Pneumonia, Ventilator-Associated; Severity of Illness Index; Treatment Outcome	2008
Hospital resource utilization with doripenem versus imipenem in the treatment of ventilator-associated pneumonia. Clinical therapeutics, 2008, Volume: 30, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Costs and Cost Analysis; Doripenem; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hospital Costs; Humans; Imipenem; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Pneumonia, Ventilator-Associated; Survival Rate; Treatment Outcome	2008

Other Studies

72 other study(ies) available for carbapenems and Ventilator-Associated Pneumonia

Article	Year
Emergence of blaNDM-1 and blaVIM producing Gram-negative bacilli in ventilator-associated pneumonia at AMR Surveillance Regional Reference Laboratory in India. PloS one, 2021, Volume: 16, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clinical Laboratory Services; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Young Adult	2021
Molecular detection of blaOXA-23 gene and blaOXA-51 gene in carbapenem resistant strains of Acinetobacter baumannii in patients with ventilator associated pneumonia at tertiary care hospitals. JPMA. The Journal of the Pakistan Medical Association, 2021, Volume: 71, Issue:11 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Humans; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Tertiary Care Centers	2021
Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection. mBio, 2022, 02-22, Volume: 13, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactams; Carbapenems; COVID-19; Drug Resistance, Multiple, Bacterial; Humans; Mice; Microbial Sensitivity Tests; Pandemics; Pneumonia, Ventilator-Associated; Tetracycline; Tigecycline; Zinc	2022
Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 2022, 05-17, Volume: 66, Issue:5 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Colistin; Humans; Pneumonia, Ventilator-Associated; Retrospective Studies; Sepsis	2022
Microbiology, empiric therapy and its impact on the outcomes of nonventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States, 2014-2019. Infection control and hospital epidemiology, 2022, Volume: 43, Issue:3 Topics: Anti-Bacterial Agents; Carbapenems; Escherichia coli; Healthcare-Associated Pneumonia; Hospitals; Humans; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Retrospective Studies; Staphylococcus aureus; United States; Ventilators, Mechanical	2022
Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective. Expert review of anti-infective therapy, 2022, Volume: 20, Issue:7 Topics: Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Pneumonia, Ventilator-Associated	2022
Prognosis of hospital-acquired pneumonia/ventilator-associated pneumonia with Stenotrophomonas maltophilia versus Klebsiella pneumoniae in intensive care unit: A retrospective cohort study. The clinical respiratory journal, 2022, Volume: 16, Issue:10 Topics: Anti-Bacterial Agents; Carbapenems; Hospitals; Humans; Intensive Care Units; Klebsiella pneumoniae; Pneumonia, Ventilator-Associated; Prognosis; Retrospective Studies; Stenotrophomonas maltophilia	2022
The risk of inappropriate empiric treatment and its outcomes based on pathogens in non-ventilated (nvHABP), ventilated (vHABP) hospital-acquired and ventilator-associated (VABP) bacterial pneumonia in the US, 2012-2019. BMC infectious diseases, 2022, Oct-05, Volume: 22, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Hospitals; Humans; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Retrospective Studies; Ventilators, Mechanical	2022
Effect of ICU quality control indicators on VAP incidence rate and mortality: a retrospective study of 1267 hospitals in China. Critical care (London, England), 2022, 12-29, Volume: 26, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Hospitals; Humans; Incidence; Intensive Care Units; Klebsiella pneumoniae; Pneumonia, Ventilator-Associated; Retrospective Studies	2022
The prevalence, presentation and outcome of colistin susceptible-only Acinetobacter Baumannii-associated pneumonia in intensive care unit: a multicenter observational study. Scientific reports, 2023, 01-04, Volume: 13, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Susceptibility; Humans; Intensive Care Units; Pneumonia, Ventilator-Associated; Prevalence; Renal Dialysis; Retrospective Studies	2023
Nomogram for predicting 90-day mortality in patients with The Journal of international medical research, 2023, Volume: 51, Issue:3 Topics: Acinetobacter baumannii; Carbapenems; Hospitals; Humans; Intensive Care Units; Nomograms; Pneumonia, Ventilator-Associated; Retrospective Studies	2023
Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19. International journal of antimicrobial agents, 2023, Volume: 62, Issue:1 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefiderocol; Colistin; COVID-19; Fosfomycin; Humans; Pneumonia, Ventilator-Associated	2023
Mortality and ventilator dependence in critically ill patients with ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2023, Volume: 56, Issue:4 Topics: Acinetobacter baumannii; Carbapenems; Critical Illness; Humans; Pneumonia, Ventilator-Associated; Retrospective Studies; Ventilators, Mechanical	2023
Evaluation of the combination treatments with intravenous fosfomycin for carbapenem-resistant Klebsiella pneumoniae. Revista da Associacao Medica Brasileira (1992), 2023, Volume: 69, Issue:11 Topics: Adult; Anti-Bacterial Agents; Carbapenems; Fosfomycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Pneumonia, Ventilator-Associated; Retrospective Studies; Sepsis	2023
Ventilator-associated pneumonia due to Stenotrophomonas maltophilia: Risk factors and outcome. The Journal of infection, 2020, Volume: 80, Issue:3 Topics: Carbapenems; Humans; Intensive Care Units; Pneumonia, Ventilator-Associated; Risk Factors; Stenotrophomonas maltophilia	2020
Antimicrobial-resistant pathogens associated with pediatric healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015-2017. Infection control and hospital epidemiology, 2020, Volume: 41, Issue:1 Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Catheter-Related Infections; Catheters, Indwelling; Centers for Disease Control and Prevention, U.S.; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Equipment Contamination; Escherichia coli; Hospitals; Humans; Infant; Infant, Newborn; Klebsiella pneumoniae; Pneumonia, Ventilator-Associated; Staphylococcus; Surgical Wound Infection; United States	2020
Ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19: Two problems, one solution? Medical hypotheses, 2020, Volume: 144 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Coinfection; Colistin; COVID-19; Drug Resistance, Bacterial; Humans; Models, Theoretical; Pneumonia, Ventilator-Associated	2020
Polymyxin for treatment of ventilator-associated pneumonia in a setting of high carbapenem resistance. PloS one, 2020, Volume: 15, Issue:8 Topics: Adult; Aged; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Hospital Mortality; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Multivariate Analysis; Pneumonia, Ventilator-Associated; Polymyxins; Probability; Survival Analysis; Time Factors	2020
Double carbapenem regimen used as salvage therapy to treat multidrug-resistant Klebsiella pneumoniae causing ventilator-associated pneumonia. Advances in respiratory medicine, 2021, Volume: 89, Issue:2 Topics: Anti-Bacterial Agents; Carbapenems; Child; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella pneumoniae; Male; Pneumonia, Ventilator-Associated; Salvage Therapy; Treatment Outcome	2021
Ventilator-associated pneumonia due to carbapenem-resistant BMJ case reports, 2021, Jul-05, Volume: 14, Issue:7 Topics: Carbapenems; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Ventilator-Associated; Providencia; Ventilators, Mechanical	2021
Activity of meropenem/vaborbactam and comparators against Gram-negative isolates from Eastern and Western European patients hospitalized with pneumonia including ventilator-associated pneumonia (2014-19). The Journal of antimicrobial chemotherapy, 2021, 09-15, Volume: 76, Issue:10 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Boronic Acids; Carbapenems; Humans; Meropenem; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated	2021
Repeated local emergence of carbapenem-resistant Microbial genomics, 2016, Volume: 2, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Drug Resistance, Bacterial; Evolution, Molecular; Genes, Bacterial; Genetic Variation; Genome, Bacterial; Humans; Phylogeny; Pneumonia, Ventilator-Associated; Recombination, Genetic; Vietnam; Whole Genome Sequencing	2016
Enhanced antimicrobial de-escalation for pneumonia in mechanically ventilated patients: a cross-over study. Critical care (London, England), 2017, 07-15, Volume: 21, Issue:1 Topics: Academic Medical Centers; Aged; Anti-Bacterial Agents; Carbapenems; Cefepime; Ceftriaxone; Cephalosporins; Cross-Over Studies; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Monobactams; Pneumonia; Pneumonia, Ventilator-Associated; Prospective Studies; Quinolones; Respiration, Artificial; Statistics, Nonparametric	2017
[Efficacy of extended-infusion of carbapenem plus sulbactam for ventilator-associated pneumonia caused by extensive drug-resistant Zhonghua yi xue za zhi, 2017, Oct-17, Volume: 97, Issue:38 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Pneumonia, Ventilator-Associated; Retrospective Studies; Sulbactam	2017
Pathogen Distribution and Antimicrobial Resistance Among Pediatric Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2011-2014. Infection control and hospital epidemiology, 2018, Volume: 39, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Catheter-Related Infections; Catheters, Indwelling; Centers for Disease Control and Prevention, U.S.; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Equipment Contamination; Escherichia coli; Hospitals; Humans; Infant; Infant, Newborn; Klebsiella pneumoniae; Pediatrics; Pneumonia, Ventilator-Associated; Staphylococcus; Surgical Wound Infection; United States	2018
Interpreting carbapenem susceptibility testing results for Pseudomonas aeruginosa. Medecine et maladies infectieuses, 2018, Volume: 48, Issue:5 Topics: beta-Lactam Resistance; Carbapenems; Disk Diffusion Antimicrobial Tests; Doripenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Reagent Strips; Sensitivity and Specificity	2018
Infection-related ventilator-associated complications in ICU patients colonised with extended-spectrum β-lactamase-producing Enterobacteriaceae. Intensive care medicine, 2018, Volume: 44, Issue:5 Topics: Aged; beta-Lactamases; Carbapenems; Carrier State; Enterobacteriaceae; Enterobacteriaceae Infections; Female; France; Humans; Intensive Care Units; Male; Pneumonia, Ventilator-Associated; Prospective Studies	2018
Emergence of carbapenem-resistant Acinetobacter pittii carrying the bla Diagnostic microbiology and infectious disease, 2019, Volume: 93, Issue:1 Topics: Acinetobacter; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Brazil; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genes, Bacterial; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Plasmids; Pneumonia, Ventilator-Associated; Recombination, Genetic; Sequence Analysis, DNA	2019
A Novel Algorithm to Analyze Epidemiology and Outcomes of Carbapenem Resistance Among Patients With Hospital-Acquired and Ventilator-Associated Pneumonia: A Retrospective Cohort Study. Chest, 2019, Volume: 155, Issue:6 Topics: Algorithms; beta-Lactam Resistance; Carbapenems; Costs and Cost Analysis; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Healthcare-Associated Pneumonia; Humans; Length of Stay; Male; Middle Aged; Outcome and Process Assessment, Health Care; Pneumonia, Ventilator-Associated; Retrospective Studies; Survival Analysis; United States	2019
Ventilator-Associated Pneumonia due to Drug-Resistant Medicina (Kaunas, Lithuania), 2019, Feb-13, Volume: 55, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Carbapenems; Cohort Studies; Drug Resistance, Multiple, Bacterial; Erythrocyte Transfusion; Female; Hospital Mortality; Hospitals, University; Humans; Intensive Care Units; Length of Stay; Lithuania; Logistic Models; Male; Middle Aged; Pneumonia, Ventilator-Associated; Retrospective Studies; Risk Factors; ROC Curve; Sex Factors	2019
A Combination Antibiogram Evaluation for Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Intensive Care Units; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; United States	2019
Clinical Impact of Antimicrobial Resistance: Using New Tools to Answer Old Questions. Chest, 2019, Volume: 155, Issue:6 Topics: Algorithms; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans; Pneumonia, Ventilator-Associated; Retrospective Studies	2019
Ventilator associated pneumonia due to carbapenem resistant microorganisms in children. Minerva pediatrica, 2019, Volume: 71, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Humans; Infant; Intensive Care Units, Pediatric; Length of Stay; Male; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors	2019
Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6 Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Colistin; Doripenem; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Pneumonia, Ventilator-Associated; Treatment Outcome	2013
Assessment of the combination of doripenem plus a fluoroquinolone against non-susceptible Acinetobacter baumannii isolates from nosocomial pneumonia patients. Journal of chemotherapy (Florence, Italy), 2013, Volume: 25, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Carbapenems; Ciprofloxacin; Doripenem; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Female; Levofloxacin; Mice; Ofloxacin; Pneumonia, Ventilator-Associated; Random Allocation; Survival Analysis	2013
Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia. International journal of antimicrobial agents, 2014, Volume: 43, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Carbapenems; Cohort Studies; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Minocycline; Pneumonia, Ventilator-Associated; Retrospective Studies; Sulbactam; Tigecycline; Treatment Outcome; Young Adult	2014
Emergence of carbapenem-resistant Acinetobacter baumannii as the major cause of ventilator-associated pneumonia in intensive care unit patients at an infectious disease hospital in southern Vietnam. Journal of medical microbiology, 2014, Volume: 63, Issue:Pt 10 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; DNA, Bacterial; Female; Genotype; Hospitals; Humans; Intensive Care Units; Male; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Pneumonia, Ventilator-Associated; Prevalence; Retrospective Studies; Vietnam; Young Adult	2014
Molecular epidemiological survey of the quinolone- and carbapenem-resistant genotype and its association with the type III secretion system in Pseudomonas aeruginosa. Journal of medical microbiology, 2015, Volume: 64, Issue:Pt 3 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Secretion Systems; Brazil; Carbapenems; Child; Child, Preschool; Cohort Studies; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Genotype; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Virulence Factors; Young Adult	2015
Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, May-01, Volume: 60, Issue:9 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Ampicillin; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Electronic Health Records; Electrophoresis, Gel, Pulsed-Field; Ethanolamines; Female; Humans; Lipid A; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Pneumonia, Ventilator-Associated; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulbactam	2015
Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia. Journal of infection in developing countries, 2015, May-18, Volume: 9, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Pneumonia, Ventilator-Associated; Renal Insufficiency; Retrospective Studies; Sulbactam; Treatment Outcome	2015
Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:8 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Intensive Care Units; Male; Middle Aged; Multiple Organ Failure; Organ Dysfunction Scores; Pneumonia, Ventilator-Associated; Retrospective Studies; Risk Factors; Thailand	2015
In vitro activity of colistin in antimicrobial combination against carbapenem-resistant Acinetobacter baumannii isolated from patients with ventilator-associated pneumonia in Vietnam. Journal of medical microbiology, 2015, Volume: 64, Issue:10 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cluster Analysis; Colistin; Drug Synergism; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Pneumonia, Ventilator-Associated; Vietnam	2015
In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia. International journal of medical sciences, 2015, Volume: 12, Issue:9 Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Colistin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia, Ventilator-Associated; Tigecycline; Young Adult	2015
National Survey of Thai Infectious Disease Physicians on Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: The Role of Infection Control Awareness. Infection control and hospital epidemiology, 2016, Volume: 37, Issue:1 Topics: Acinetobacter baumannii; Adult; Carbapenems; Certification; Clinical Competence; Drug Resistance, Bacterial; Female; Humans; Infection Control; Infectious Disease Medicine; Male; Middle Aged; Pneumonia, Ventilator-Associated; Practice Patterns, Physicians'; Referral and Consultation; Thailand; Treatment Outcome	2016
Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia in the neonate: A case-case-control study. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016, Volume: 22, Issue:7 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cephalosporins; Drug Resistance, Bacterial; Female; Humans; Infant; Infant, Newborn; Male; Pneumonia, Ventilator-Associated; Pulmonary Surfactants; Risk Factors; Treatment Outcome	2016
Pharmacodynamics of carbapenems for the treatment of Pseudomonas aeruginosa ventilator-associated pneumonia: associations with clinical outcome and recurrence. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Carbapenems; Disk Diffusion Antimicrobial Tests; Doripenem; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Recurrence; Thienamycins; Treatment Outcome	2016
Alternatives to carbapenems in ventilator-associated pneumonia due to ESBL-producing Enterobacteriaceae. The Journal of infection, 2016, Volume: 73, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated	2016
De-escalation of pivotal beta-lactam in ventilator-associated pneumonia does not impact outcome and marginally affects MDR acquisition. Intensive care medicine, 2016, Volume: 42, Issue:12 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Pneumonia, Ventilator-Associated; Retrospective Studies	2016
Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam. Clinical therapeutics, 2016, Volume: 38, Issue:9 Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Tigecycline; Vietnam	2016
Control of carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit of a teaching hospital in Southern Italy. BMC infectious diseases, 2016, Dec-12, Volume: 16, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Carbapenems; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genotype; Humans; Infection Control; Intensive Care Units; Italy; Male; Middle Aged; Molecular Typing; Pneumonia, Ventilator-Associated; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization	2016
Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii. International journal of antimicrobial agents, 2008, Volume: 32, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Rifampin; Treatment Outcome	2008
[Carbapenem restriction reduce the incidence of multidrug-resistant Acinetobacter baumannii in ventilator associated pneumonia]. Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue, 2009, Volume: 21, Issue:4 Topics: Acinetobacter baumannii; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Pneumonia, Ventilator-Associated	2009
Efficacy of intravenous infusion of doripenem. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1 Topics: Carbapenems; Cross Infection; Doripenem; Humans; Imipenem; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated	2009
Safety of intravenous infusion of doripenem. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1 Topics: Anti-Bacterial Agents; Area Under Curve; Carbapenems; Cross Infection; Doripenem; Drug Stability; Drug-Related Side Effects and Adverse Reactions; Humans; Hypersensitivity; Infusions, Intravenous; Injections, Intravenous; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Quality Control	2009
Clinical and economic consequences of ventilator-associated pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1 Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Health Care Costs; Hospital Mortality; Humans; Imipenem; Intensive Care Units; Length of Stay; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Severity of Illness Index	2009
Economic assessment of doripenem versus imipenem in the treatment of ventilator-associated pneumonia. Journal of medical economics, 2010, Volume: 13, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Cost-Benefit Analysis; Decision Support Techniques; Doripenem; Hospitalization; Humans; Imipenem; Intensive Care Units; Length of Stay; Middle Aged; Models, Economic; Monte Carlo Method; Pneumonia, Ventilator-Associated; Probability; Respiration, Artificial; Time Factors; United States	2010
Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes. Infection, 2010, Volume: 38, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheter-Related Infections; Cross Infection; Drug Resistance, Bacterial; Female; Greece; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Regression Analysis; Risk Factors	2010
Medical resource utilization among patients with ventilator-associated pneumonia: pooled analysis of randomized studies of doripenem versus comparators. Critical care (London, England), 2010, Volume: 14, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Clinical Trials, Phase III as Topic; Doripenem; Female; Health Resources; Humans; Imipenem; Length of Stay; Male; Middle Aged; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Prospective Studies; Randomized Controlled Trials as Topic; Tazobactam; Treatment Outcome	2010
[A case of hospital-acquired pneumonia caused by intermediately susceptible carbapenem Acinetobacter baumannii]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2010, Volume: 84, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Carbapenems; Cross Infection; Humans; Male; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Quinolones	2010
Cost-effectiveness model of empiric doripenem compared with imipenem-cilastatin in ventilator-associated pneumonia. Surgical infections, 2010, Volume: 11, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Cost-Benefit Analysis; Doripenem; Drug Combinations; Humans; Imipenem; Length of Stay; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Quality-Adjusted Life Years; Young Adult	2010
Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia. The European respiratory journal, 2011, Volume: 37, Issue:6 Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Europe; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Piperacillin; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Quinolones; Respiration, Artificial; Severity of Illness Index; Treatment Outcome	2011
Carbapenem-resistant OXA-23-producing Acinetobacter baumannii isolates causing ventilator-associated pneumonia. American journal of infection control, 2010, Volume: 38, Issue:8 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Brazil; Carbapenems; Critical Care; Drug Resistance, Bacterial; Humans; Intensive Care Units; Pneumonia, Ventilator-Associated	2010
First identification of blaIMI-1 in an Enterobacter cloacae clinical isolate from France. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3 Topics: Adult; Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacter cloacae; Enterobacteriaceae Infections; France; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Tazobactam	2012
Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin. International journal of antimicrobial agents, 2012, Volume: 39, Issue:3 Topics: Carbapenems; Colistin; Cross Infection; Doripenem; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fosfomycin; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Retrospective Studies; Time Factors	2012
Characteristics of carbapenem-resistant Pseudomonas aeruginosa strains in patients with ventilator-associated pneumonia in intensive care units. Medicina (Kaunas, Lithuania), 2011, Volume: 47, Issue:12 Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Intensive Care Units; Lithuania; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections	2011
What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance. International journal of antimicrobial agents, 2012, Volume: 39, Issue:6 Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Critical Illness; Cross Infection; Doripenem; Humans; Kidney; Metabolic Clearance Rate; Pneumonia; Pneumonia, Ventilator-Associated; Randomized Controlled Trials as Topic	2012
Doripenem: excess mortality. Prescrire international, 2012, Volume: 21, Issue:130 Topics: Anti-Bacterial Agents; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Doripenem; Drug Combinations; Early Termination of Clinical Trials; Evidence-Based Medicine; Humans; Imipenem; Pneumonia, Ventilator-Associated; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Treatment Outcome	2012
A week seems to be weak: tailoring duration of antibiotic treatment in Gram-negative ventilator-associated pneumonia. Critical care (London, England), 2013, Jan-21, Volume: 17, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Cilastatin; Female; Humans; Imipenem; Male; Pneumonia, Ventilator-Associated	2013
Contaminated oral intubation equipment associated with an outbreak of carbapenem-resistant Pseudomonas in an intensive care unit. The Journal of hospital infection, 2007, Volume: 65, Issue:1 Topics: Carbapenems; Cross Infection; Disease Outbreaks; Disinfection; Drug Resistance, Bacterial; Equipment Contamination; Equipment Reuse; Hospitals, University; Humans; Immunocompromised Host; Intensive Care Units; Intubation, Intratracheal; Japan; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Respiration, Artificial	2007
Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa. Intensive care medicine, 2007, Volume: 33, Issue:9 Topics: Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Colistin; Cross Infection; Disease Outbreaks; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Hand Disinfection; Humans; Intensive Care Units; Logistic Models; Male; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Risk Factors; Suction	2007
Doripenem (Doribax)--a new parenteral carbapenem. The Medical letter on drugs and therapeutics, 2008, Jan-28, Volume: 50, Issue:1278 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Drug Administration Schedule; Drug Interactions; Humans; Infusions, Intravenous; Pneumonia, Ventilator-Associated; Treatment Outcome; Urinary Tract Infections	2008
Doripenem (doribax)--a new parenteral carbapenem. Obstetrics and gynecology, 2008, Volume: 111, Issue:5 Topics: Carbapenems; Cross Infection; Doripenem; Female; Humans; Pneumonia; Pneumonia, Ventilator-Associated; Urinary Tract Infections	2008